This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 1948 |
| SARS | 1208 |
| Health | 1087 |
| • | 777 |
| China | 717 |
| Risk | 692 |
| United | 589 |
| States | 473 |
| Table | 459 |
| CI | 452 |
| HIV | 443 |
| CoV-2 | 402 |
| World | 345 |
| US | 340 |
| National | 333 |
| UK | 329 |
| Disease | 327 |
| Fig | 322 |
| EU | 302 |
| Study | 296 |
| Africa | 250 |
| European | 248 |
| New | 245 |
| Europe | 240 |
| International | 236 |
| Coronavirus | 234 |
| MS | 230 |
| Organization | 228 |
| Research | 224 |
| Singapore | 220 |
| A | 219 |
| C | 218 |
| ABSTRACT | 215 |
| Control | 213 |
| meta | 211 |
| South | 209 |
| B | 209 |
| Ebola | 206 |
| Global | 204 |
| Group | 203 |
| Association | 203 |
| Management | 196 |
| Background | 196 |
| ICU | 189 |
| H1N1 | 188 |
| Lyme | 187 |
| U.S. | 184 |
| mg | 183 |
| CDC | 181 |
| Government | 178 |
| Commission | 176 |
| sha | 175 |
| Asia | 175 |
| PPE | 173 |
| Prevention | 172 |
| May | 171 |
| J | 170 |
| March | 165 |
| CPS | 164 |
| Public | 163 |
| Panel | 161 |
| Committee | 161 |
| Safety | 156 |
| Assessment | 155 |
| Italy | 152 |
| D | 152 |
| DOI | 152 |
| Society | 151 |
| MERS | 150 |
| II | 150 |
| TB | 149 |
| Analysis | 149 |
| England | 146 |
| Council | 146 |
| Netherlands | 144 |
| EFSA | 144 |
| WHO | 143 |
| H5N1 | 142 |
| Care | 141 |
| Human | 141 |
| University | 139 |
| April | 138 |
| Wuhan | 136 |
| S. | 132 |
| American | 132 |
| ABCD | 132 |
| January | 131 |
| America | 129 |
| Institute | 128 |
| Report | 127 |
| Influenza | 126 |
| EC | 126 |
| Australia | 124 |
| Food | 123 |
| BMI | 123 |
| USA | 123 |
| Review | 122 |
| Canada | 122 |
| AI | 122 |
| Pandemic | 121 |
| AIDS | 120 |
| Vietnam | 117 |
| Department | 117 |
| Alzheimer | 117 |
| Development | 113 |
| C. | 111 |
| Scientific | 110 |
| Kingdom | 110 |
| T | 108 |
| Social | 108 |
| Animal | 106 |
| CAP | 106 |
| H7N9 | 106 |
| Network | 105 |
| WTP | 104 |
| Salmonella | 103 |
| Cancer | 103 |
| East | 99 |
| Data | 99 |
| Index | 98 |
| Impact | 98 |
| Americans | 98 |
| Security | 97 |
| MI | 97 |
| Hendra | 97 |
| CC | 97 |
| BP | 97 |
| M. | 96 |
| North | 95 |
| Agency | 95 |
| E. | 95 |
| Covid-19 | 95 |
| Model | 94 |
| HBV | 94 |
| Science | 93 |
| S | 93 |
| CVD | 93 |
| VTEC | 92 |
| PCR | 92 |
| Center | 92 |
| HR | 91 |
| France | 91 |
| PH | 90 |
| York | 90 |
| Germany | 89 |
| Diseases | 88 |
| Clinical | 88 |
| West | 88 |
| System | 87 |
| Use | 84 |
| J. | 83 |
| FCI | 83 |
| Evaluation | 83 |
| Medicine | 81 |
| Infectious | 81 |
| Hospital | 81 |
| fi | 80 |
| State | 80 |
| Appendix | 79 |
| Medical | 79 |
| February | 78 |
| Japan | 77 |
| Union | 76 |
| High | 76 |
| Staphylococcus | 75 |
| MRSA | 75 |
| India | 75 |
| Office | 74 |
| Korea | 74 |
| Crisis | 74 |
| Survey | 73 |
| R | 73 |
| Brazil | 73 |
| Chen | 72 |
| CoV | 72 |
| Methods | 72 |
| Financial | 71 |
| Figure | 71 |
| Pregnancy | 70 |
| N | 70 |
| July | 70 |
| December | 70 |
| DR | 70 |
| < | 69 |
| Campylobacter | 69 |
| Healthcare | 69 |
| Directive | 69 |
| GVHD | 69 |
| Centers | 69 |
| ICNIRP | 69 |
| fl | 69 |
| nan | 69 |
| NAI | 69 |
| Turkey | 69 |
| CONTAM | 68 |
| Guidelines | 68 |
| Protection | 67 |
| Chronic | 67 |
| CT | 67 |
| COPD | 67 |
| ADRD | 67 |
| Taiwan | 66 |
| Kong | 66 |
| Environmental | 66 |
| ARB | 66 |
| Emergency | 65 |
| Economic | 65 |
| Registry | 65 |
| Escherichia | 65 |
| F | 64 |
| kg | 63 |
| Project | 63 |
| Occupational | 63 |
| Hong | 63 |
| remdesivir | 62 |
| Wang | 62 |
| Disaster | 62 |
| Cox | 62 |
| CMV | 62 |
| September | 61 |
| Beck | 61 |
| Bank | 60 |
| Area | 60 |
| Medicare | 60 |
| Community | 60 |
| NHS | 60 |
| College | 59 |
| B. | 59 |
| Biological | 59 |
| ARDS | 59 |
| HCC | 59 |
| HRP | 59 |
| M | 59 |
| uenza | 58 |
| Systems | 58 |
| Respiratory | 58 |
| June | 58 |
| I | 58 |
| California | 58 |
| Britain | 57 |
| ALM | 57 |
| Syndrome | 57 |
| General | 57 |
| Veterinary | 56 |
| Response | 56 |
| Regions | 56 |
| FDA | 56 |
| Drug | 56 |
| L. | 55 |
| ARTI | 55 |
| BY | 55 |
| Centre | 55 |
| HCQ | 55 |
| HPAI | 55 |
| HSCT | 55 |
| Information | 55 |
| Transmission | 55 |
| Nations | 55 |
| Policy | 55 |
| RR | 55 |
| Spain | 55 |
| Task | 55 |
| Ministry | 55 |
| Program | 54 |
| London | 54 |
| HCWs | 54 |
| Epidemiology | 54 |
| DM | 54 |
| A. | 54 |
| IRGC | 53 |
| A(H7N9 | 53 |
| Advisory | 53 |
| Ethics | 53 |
| K | 53 |
| Middle | 53 |
| ND | 53 |
| Working | 53 |
| Great | 52 |
| CHD | 52 |
| Effect | 52 |
| EBV | 52 |
| H. | 52 |
| L | 52 |
| Welfare | 52 |
| NSAID | 51 |
| Life | 51 |
| IBD | 51 |
| Central | 51 |
| ACE2 | 51 |
| N95 | 50 |
| CRP | 50 |
| Monte | 50 |
| Technology | 50 |
| PPI | 50 |
| Van | 50 |
| Smith | 49 |
| Practice | 49 |
| Industry | 49 |
| Emerging | 49 |
| AMI | 49 |
| covid-19 | 48 |
| Zealand | 48 |
| Water | 48 |
| RT | 48 |
| Efficacy | 48 |
| Chinese | 48 |
| Carlo | 48 |
| Commons | 46 |
| Act | 46 |
| IU | 46 |
| Lancet | 46 |
| Statistics | 46 |
| R. | 45 |
| P. | 45 |
| OECD | 45 |
| Non | 45 |
| Li | 45 |
| ED | 45 |
| Deep | 45 |
| Force | 44 |
| Administration | 44 |
| Article | 44 |
| Case | 44 |
| Communication | 44 |
| Creative | 44 |
| S1 | 44 |
| Infection | 44 |
| Virus | 44 |
| IoT | 44 |
| van | 44 |
| November | 44 |
| NRCPs | 44 |
| NICU | 43 |
| De | 43 |
| French | 43 |
| Law | 43 |
| III | 43 |
| October | 43 |
| PWUD | 43 |
| Services | 43 |
| medRxiv | 43 |
| Factors | 42 |
| August | 42 |
| Barr | 42 |
| COVID | 42 |
| Cyber | 42 |
| Epstein | 42 |
| Heart | 42 |
| Finland | 42 |
| Foundation | 42 |
| Infections | 42 |
| News | 42 |
| Theory | 42 |
| Treatment | 42 |
| Legionella | 41 |
| African | 41 |
| Ben | 41 |
| Chain | 41 |
| City | 41 |
| Exposure | 41 |
| Supplementary | 41 |
| NC | 41 |
| USEPA | 41 |
| Republic | 41 |
| VAERS | 41 |
| School | 41 |
| SS | 40 |
| RCT | 40 |
| Population | 40 |
| HT | 40 |
| Antiretroviral | 40 |
| Sweden | 40 |
| Trial | 39 |
| GI | 39 |
| Beijing | 39 |
| Board | 39 |
| EVC | 39 |
| Workers | 39 |
| 39 | |
| Governance | 39 |
| TBI | 39 |
| VTE | 39 |
| 8) | 38 |
| Opinion | 38 |
| HCV | 38 |
| Dr. | 38 |
| Regulation | 38 |
| Hepatitis | 38 |
| RNA | 38 |
| Indonesia | 38 |
| hepatitis | 37 |
| Liu | 37 |
| UN | 37 |
| D. | 37 |
| DHCP | 37 |
| DIC | 37 |
| Framework | 37 |
| IV | 37 |
| CAC | 37 |
| Mexico | 37 |
| Pseudomonas | 37 |
| Quality | 37 |
| SES | 37 |
| Standards | 37 |
| Tourism | 37 |
| ADG | 36 |
| Cognitive | 36 |
| HIV-1 | 36 |
| Networks | 36 |
| Province | 36 |
| Service | 36 |
| WHAM | 36 |
| CAPM | 35 |
| Engineering | 35 |
| HLA | 35 |
| Low | 35 |
| Mycobacterium | 35 |
| O157 | 35 |
| OSH | 35 |
| PMI | 35 |
| PU | 35 |
| Red | 35 |
| Renn | 35 |
| defi | 35 |
| von | 35 |
| Σ | 35 |
| Annex | 34 |
| CDT | 34 |
| Declaration | 34 |
| GDP | 34 |
| HSW | 34 |
| Hazards | 34 |
| Johnson | 34 |
| LMIC | 34 |
| PSI | 34 |
| Pacific | 34 |
| Region | 34 |
| Sciences | 34 |
| Team | 34 |
| Thailand | 34 |
| VZV | 34 |
| der | 34 |
| i | 34 |
| Age | 33 |
| Cross | 33 |
| Factor | 33 |
| Guide | 33 |
| IDS | 33 |
| IHR | 33 |
| Med | 33 |
| ILI | 33 |
| Practices | 33 |
| Rights | 33 |
| White | 33 |
| σ | 33 |
| Meta | 33 |
| Organisation | 32 |
| D3 | 32 |
| Database | 32 |
| H | 32 |
| IARC | 32 |
| Ibid | 32 |
| Novel | 32 |
| G | 32 |
| Portugal | 32 |
| Shi | 32 |
| Standard | 32 |
| Studies | 32 |
| Surveillance | 32 |
| analysis | 32 |
| Russia | 32 |
| disease | 32 |
| GOF | 31 |
| MSW | 31 |
| ISO | 31 |
| INH | 31 |
| ILO | 31 |
| ICS | 31 |
| HA | 31 |
| Geneva | 31 |
| Civil | 31 |
| G. | 31 |
| E | 31 |
| Based | 31 |
| BIOHAZ | 31 |
| BCG | 31 |
| Aven | 31 |
| Nature | 31 |
| Natural | 31 |
| Trade | 31 |
| OR | 31 |
| PA | 31 |
| signifi | 31 |
| eff | 31 |
| acyclovir | 31 |
| Y | 31 |
| Western | 31 |
| Wales | 31 |
| Vaccine | 31 |
| Toronto | 31 |
| TNF | 31 |
| Strategy | 31 |
| Special | 31 |
| Slovic | 31 |
| SEC | 31 |
| Questionnaire | 31 |
| PWID | 31 |
| Federal | 30 |
| Intelligence | 30 |
| Laboratory | 30 |
| Cohen | 30 |
| Code | 30 |
| LDA | 30 |
| Joint | 30 |
| OSHA | 30 |
| health | 30 |
| Process | 30 |
| PubMed | 30 |
| Reduction | 30 |
| Work | 30 |
| Paper | 30 |
| FFP | 29 |
| AHAW | 29 |
| Agriculture | 29 |
| Business | 29 |
| Cd | 29 |
| Children | 29 |
| Critical | 29 |
| DNA | 29 |
| Environment | 29 |
| Convention | 29 |
| HF | 29 |
| Southern | 29 |
| I. | 29 |
| oseltamivir | 29 |
| association | 29 |
| Uncertainty | 29 |
| Washington | 29 |
| Rapid | 29 |
| Lee | 29 |
| Journal | 29 |
| Climate | 28 |
| Future | 28 |
| English | 28 |
| Education | 28 |
| EPA | 28 |
| Defense | 28 |
| Cochrane | 28 |
| Academy | 28 |
| Cardiovascular | 28 |
| CDA | 28 |
| Brain | 28 |
| Approach | 28 |
| ASA | 28 |
| Hazard | 28 |
| HCT | 28 |
| Regulations | 28 |
| Helsinki | 28 |
| SLR | 28 |
| Zhang | 28 |
| War | 28 |
| Unit | 28 |
| Immunization | 28 |
| T. | 28 |
| SPSS | 28 |
| Times | 28 |
| Q | 28 |
| Pearson | 28 |
| Northern | 28 |
| NSAIDs | 28 |
| Monitoring | 28 |
| Industrial | 28 |
| nan | 27 |
| BSE | 27 |
| CCS | 27 |
| Cohort | 27 |
| Cronbach | 27 |
| Decision | 27 |
| Dutch | 27 |
| GAEN | 27 |
| ICI | 27 |
| Michael | 27 |
| Hydroxychloroquine | 27 |
| NRCP | 27 |
| Southeast | 27 |
| | | 27 |
| X | 27 |
| Value | 27 |
| VT | 27 |
| Neural | 27 |
| SIR | 27 |
| SD | 27 |
| ⁄ | 27 |
| Outbreak | 27 |
| LSTM | 26 |
| Adults | 26 |
| Affairs | 26 |
| CFA | 26 |
| Calves | 26 |
| Cardiology | 26 |
| Chemical | 26 |
| County | 26 |
| GP | 26 |
| Guardian | 26 |
| Huang | 26 |
| Integrated | 26 |
| Malaria | 26 |
| specifi | 26 |
| Systematic | 26 |
| ¼ | 26 |
| NIH | 26 |
| doc_id | 26 |
| anti | 26 |
| Trust | 26 |
| Yang | 26 |
| Resilience | 26 |
| RSV | 26 |
| Planning | 26 |
| Patient | 26 |
| NOC | 26 |
| Behavior | 25 |
| Chongqing | 25 |
| CTI | 25 |
| COPC | 25 |
| Burden | 25 |
| Constitution | 25 |
| Authority | 25 |
| Action | 25 |
| Access | 25 |
| ATS | 25 |
| Consensus | 25 |
| rst | 25 |
| EN | 25 |
| Programme | 25 |
| Flu | 25 |
| Zika | 25 |
| River | 25 |
| β | 25 |
| Norway | 25 |
| MH | 25 |
| Insurance | 25 |
| Helicobacter | 25 |
| GBS | 24 |
| Member | 24 |
| Martin | 24 |
| Markov | 24 |
| MOH | 24 |
| Ixodes | 24 |
| IFD | 24 |
| Homeland | 24 |
| Biosecurity | 24 |
| Enterobacteriaceae | 24 |
| Conference | 24 |
| COVID‐19 | 24 |
| Black | 24 |
| Antimicrobial | 24 |
| Activity | 24 |
| OS | 24 |
| NOS3 | 24 |
| − | 24 |
| Poisson | 24 |
| Taylor | 24 |
| Primary | 24 |
| benefi | 24 |
| Williams | 24 |
| WB | 24 |
| Tool | 24 |
| Time | 24 |
| Technologies | 24 |
| infl | 24 |
| T2DM | 24 |
| Summary | 24 |
| Shanghai | 24 |
| Self | 24 |
| SEP | 24 |
| SBP | 24 |
| Systemic | 24 |
| Denmark | 23 |
| Innovation | 23 |
| ICT | 23 |
| HSRQ | 23 |
| HPV | 23 |
| Guideline | 23 |
| F. | 23 |
| CSF | 23 |
| David | 23 |
| Crohn | 23 |
| Broom | 23 |
| Borrelia | 23 |
| Bio | 23 |
| M2 | 23 |
| Knowledge | 23 |
| Learning | 23 |
| ML | 23 |
| SNP | 23 |
| scada | 23 |
| ritonavir | 23 |
| pandemic | 23 |
| Young | 23 |
| Watch | 23 |
| Statistical | 23 |
| Women | 23 |
| RCTs | 23 |
| Prediction | 23 |
| Pneumonia | 23 |
| PE | 23 |
| NDI | 23 |
| Mental | 23 |
| MMR | 23 |
| Day | 22 |
| IL-6 | 22 |
| IDSA | 22 |
| Hubei | 22 |
| HMM | 22 |
| HHRA | 22 |
| Green | 22 |
| FAO | 22 |
| Eq | 22 |
| AUC | 22 |
| Contaminants | 22 |
| Congo | 22 |
| Classification | 22 |
| COSRE | 22 |
| Asian | 22 |
| Amazon | 22 |
| IQR | 22 |
| -1 | 22 |
| IM | 22 |
| Scotland | 22 |
| Iran | 22 |
| Register | 22 |
| Ireland | 22 |
| zanamivir | 22 |
| trimethoprim | 22 |
| sciences | 22 |
| herpes | 22 |
| Suicide | 22 |
| Saudi | 22 |
| S2 | 22 |
| Viet | 22 |
| Part | 22 |
| Nam | 22 |
| Park | 22 |
| Mediterranean | 22 |
| NGOs | 22 |
| MRI | 22 |
| OIE | 22 |
| PMA | 22 |
| ELBWIs | 21 |
| IGF | 21 |
| Mass | 21 |
| Hall | 21 |
| Guy | 21 |
| Guidance | 21 |
| Forum | 21 |
| Florida | 21 |
| Effectiveness | 21 |
| Economics | 21 |
| ADT | 21 |
| Division | 21 |
| COPCs | 21 |
| COMISURV | 21 |
| CHB | 21 |
| British | 21 |
| Bluetooth | 21 |
| Bayesian | 21 |
| Asthma | 21 |
| AMR | 21 |
| ACC | 21 |
| Int | 21 |
| Handwashing | 21 |
| Mobile | 21 |
| Strategic | 21 |
| Nile | 21 |
| ± | 21 |
| metronidazole | 21 |
| gondii | 21 |
| Zoonotic | 21 |
| Travel | 21 |
| Tables | 21 |
| TIA | 21 |
| Switzerland | 21 |
| Tuberculosis | 21 |
| SVC | 21 |
| Remdesivir | 21 |
| Professor | 21 |
| President | 21 |
| Physical | 21 |
| PHC | 21 |
| PCa | 21 |
| PCBs | 21 |
| OpenSAFELY | 21 |
| SMX | 21 |
| Guangdong | 20 |
| Epidemiological | 20 |
| Expert | 20 |
| Family | 20 |
| GIS | 20 |
| Growth | 20 |
| Latin | 20 |
| IEC | 20 |
| IR | 20 |
| Kelly | 20 |
| Kim | 20 |
| Director | 20 |
| Electronic | 20 |
| AWQC | 20 |
| Detection | 20 |
| Design | 20 |
| CKD | 20 |
| CFR | 20 |
| Biosafety | 20 |
| Behaviour | 20 |
| Australian | 20 |
| Attribution | 20 |
| Anders | 20 |
| Agent | 20 |
| Lung | 20 |
| AHA | 20 |
| Lin | 20 |
| LMWH | 20 |
| M5 | 20 |
| Section | 20 |
| τb | 20 |
| Miller | 20 |
| uconazole | 20 |
| mmol | 20 |
| max | 20 |
| fox | 20 |
| den | 20 |
| chemoprophylaxis | 20 |
| Veal | 20 |
| Utrecht | 20 |
| Streptococcus | 20 |
| Strategies | 20 |
| Spearman | 20 |
| azithromycin | 20 |
| Risks | 20 |
| Perception | 20 |
| Regional | 20 |
| Mortality | 20 |
| Müller | 20 |
| PTSD | 20 |
| PLC | 20 |
| Peter | 20 |
| Plan | 20 |
| Poland | 20 |
| R0 | 20 |
| Models | 20 |
| HRV | 19 |
| Home | 19 |
| HTLV | 19 |
| Hajj | 19 |
| Handbook | 19 |
| Healthy | 19 |
| K. | 19 |
| IBM | 19 |
| Immunity | 19 |
| Initiative | 19 |
| Jensen | 19 |
| Lombardy | 19 |
| Go | 19 |
| Gram | 19 |
| ABM | 19 |
| GM | 19 |
| Fifth | 19 |
| Digital | 19 |
| Congress | 19 |
| Childhood | 19 |
| CD4 | 19 |
| Brown | 19 |
| BC | 19 |
| Alliance | 19 |
| AIC | 19 |
| ACS | 19 |
| ACE | 19 |
| M1 | 19 |
| Long | 19 |
| Arabia | 19 |
| MDR | 19 |
| Swedish | 19 |
| Morgan | 19 |
| γ | 19 |
| para | 19 |
| ng | 19 |
| environ | 19 |
| author(s | 19 |
| amoxicillin | 19 |
| Wu | 19 |
| Threats | 19 |
| Thomas | 19 |
| Therapy | 19 |
| TRM | 19 |
| TMP | 19 |
| ibrutinib | 19 |
| Sustainable | 19 |
| Recommendation | 19 |
| Sustainability | 19 |
| PCB | 19 |
| PageRank | 19 |
| Preparedness | 19 |
| ROS | 19 |
| Plasmodium | 19 |
| Recommendations | 19 |
| Resistance | 19 |
| SME | 19 |
| Saúde | 19 |
| Supplemental | 19 |
| Kasperson | 18 |
| ECDC | 18 |
| Investigation | 18 |
| Institutes | 18 |
| Inc. | 18 |
| ICD | 18 |
| Hygiene | 18 |
| GMP | 18 |
| First | 18 |
| EMF | 18 |
| CA | 18 |
| Diabetes | 18 |
| Czeizel | 18 |
| Clark | 18 |
| Chicago | 18 |
| Census | 18 |
| CAD | 18 |
| Biotechnology | 18 |
| Austin | 18 |
| ACIP | 18 |
| Modeling | 18 |
| Klebsiella | 18 |
| People | 18 |
| Novartis | 18 |
| Wald | 18 |
| ∆u | 18 |
| One | 18 |
| series | 18 |
| nevirapine | 18 |
| nd | 18 |
| m2 | 18 |
| classifi | 18 |
| a1111111111 | 18 |
| Wave | 18 |
| ed | 18 |
| Varicella | 18 |
| Supercourse | 18 |
| VSD | 18 |
| ROC | 18 |
| Structure | 18 |
| Protocol | 18 |
| Supply | 18 |
| Svensson | 18 |
| U. | 18 |
| CoV2 | 17 |
| Guillain | 17 |
| Genetic | 17 |
| GVCs | 17 |
| HHI | 17 |
| Finance | 17 |
| Fama | 17 |
| FF | 17 |
| ER | 17 |
| DURC | 17 |
| Consortium | 17 |
| Artificial | 17 |
| Chi | 17 |
| Century | 17 |
| COV-2 | 17 |
| Banking | 17 |
| Bangladesh | 17 |
| Balloon | 17 |
| BWC | 17 |
| BBC | 17 |
| Associated | 17 |
| Anthrax | 17 |
| Hg | 17 |
| HP | 17 |
| cortex | 17 |
| Houtman | 17 |
| Plant | 17 |
| John | 17 |
| zoster | 17 |
| lopinavir | 17 |
| jejuni | 17 |
| V | 17 |
| U | 17 |
| Texas | 17 |
| Springer | 17 |
| Scholar | 17 |
| ROI | 17 |
| da | 17 |
| Pediatric | 17 |
| Open | 17 |
| Level | 17 |
| Pb | 17 |
| Market | 17 |
| Online | 17 |
| Outcomes | 17 |
| PSA | 17 |
| PUD | 17 |
| Patients | 17 |
| Energy | 16 |
| IPD | 16 |
| Features | 16 |
| GLMM | 16 |
| GLS | 16 |
| HBM | 16 |
| HGT | 16 |
| La | 16 |
| Indicators | 16 |
| Jones | 16 |
| King | 16 |
| M4 | 16 |
| MA | 16 |
| MHO | 16 |
| Dementia | 16 |
| Depression | 16 |
| Avian | 16 |
| Delta | 16 |
| Dairy | 16 |
| DVT | 16 |
| DFE | 16 |
| DBP | 16 |
| Criteria | 16 |
| Change | 16 |
| CCEMG | 16 |
| CABM | 16 |
| Bioterrorism | 16 |
| Andrew | 16 |
| Alcohol | 16 |
| APT | 16 |
| AMG | 16 |
| Marburg | 16 |
| MRP | 16 |
| Brocal | 16 |
| Material | 16 |
| Wei | 16 |
| Schmidt | 16 |
| Second | 16 |
| Sun | 16 |
| Trials | 16 |
| Valley | 16 |
| Vulnerability | 16 |
| del | 16 |
| SCDF | 16 |
| des | 16 |
| effi | 16 |
| hydroxychloroquine | 16 |
| ij | 16 |
| multicentre | 16 |
| Measurement | 16 |
| Scale | 16 |
| social | 16 |
| Reporting | 16 |
| Olympic | 16 |
| Radiation | 16 |
| Minsky | 16 |
| Multiple | 16 |
| Nigeria | 16 |
| Nurses | 16 |
| Ohio | 16 |
| OHS | 16 |
| Optimal | 16 |
| PAF | 16 |
| Parliament | 16 |
| Parties | 16 |
| Pneumocystis | 16 |
| RC | 16 |
| RCVS | 16 |
| GBD | 15 |
| IC | 15 |
| GPs | 15 |
| GRK4 | 15 |
| HACCP | 15 |
| HPA | 15 |
| Hill | 15 |
| Hopkins | 15 |
| Hurricane | 15 |
| Multi | 15 |
| ICC | 15 |
| IgE | 15 |
| Immune | 15 |
| Khan | 15 |
| M6 | 15 |
| MCDA | 15 |
| Minister | 15 |
| NDL | 15 |
| Eastern | 15 |
| Epidemic | 15 |
| AP | 15 |
| Diwekar | 15 |
| Decree | 15 |
| ABC | 15 |
| ADI | 15 |
| OSA | 15 |
| Abstract | 15 |
| Analog | 15 |
| BRT | 15 |
| Bao | 15 |
| Box | 15 |
| Chloroquine | 15 |
| Codex | 15 |
| Comprehensive | 15 |
| Conservation | 15 |
| Court | 15 |
| DA | 15 |
| DL | 15 |
| DM2 | 15 |
| Daily | 15 |
| NLR | 15 |
| Indian | 15 |
| Ocean | 15 |
| Y. | 15 |
| Terrorism | 15 |
| Toxocara | 15 |
| Trends | 15 |
| Typhimurium | 15 |
| V. | 15 |
| Vector | 15 |
| W | 15 |
| W. | 15 |
| aids | 15 |
| Support | 15 |
| alfa | 15 |
| angiotensinogen | 15 |
| bTB | 15 |
| control | 15 |
| ΔWTP | 15 |
| ∆T | 15 |
| −1 | 15 |
| Oxford | 15 |
| Swiss | 15 |
| Weapons | 15 |
| Stability | 15 |
| RD | 15 |
| Southam | 15 |
| Pakistan | 15 |
| Perspectives | 15 |
| Political | 15 |
| Press | 15 |
| Preterm | 15 |
| Principles | 15 |
| RBC | 15 |
| RI | 15 |
| Resource | 15 |
| Rh | 15 |
| Rio | 15 |
| Robert | 15 |
| SCVPH | 15 |
| SRA | 15 |
| Severe | 15 |
| PHO | 15 |
| Greece | 14 |
| Fisher | 14 |
| Giardia | 14 |
| GKX | 14 |
| Framingham | 14 |
| Evans | 14 |
| Fasciola | 14 |
| Exchange | 14 |
| HCP | 14 |
| Effects | 14 |
| Guan | 14 |
| Issues | 14 |
| HCW | 14 |
| HDL | 14 |
| House | 14 |
| Incidence | 14 |
| Interventions | 14 |
| Introduction | 14 |
| Isolation | 14 |
| Issue | 14 |
| Jamrozik | 14 |
| Kaplan | 14 |
| EULAR | 14 |
| EUR | 14 |
| Allen | 14 |
| EPIC | 14 |
| ELISA | 14 |
| Labour | 14 |
| Acinetobacter | 14 |
| Air | 14 |
| Alimentarius | 14 |
| Antibody | 14 |
| Baker | 14 |
| Behavioral | 14 |
| Benefit | 14 |
| Biobank | 14 |
| Biology | 14 |
| Birth | 14 |
| Body | 14 |
| Building | 14 |
| Characteristics | 14 |
| Child | 14 |
| Computer | 14 |
| Corporation | 14 |
| DJS | 14 |
| DNN | 14 |
| Diagnosis | 14 |
| Drinking | 14 |
| Labor | 14 |
| Type | 14 |
| Levels | 14 |
| Selgelid | 14 |
| Seroprevalence | 14 |
| Shah | 14 |
| SpO | 14 |
| Stress | 14 |
| 14 | |
| VA | 14 |
| VIII | 14 |
| Watson | 14 |
| ciency | 14 |
| diff | 14 |
| ective | 14 |
| el | 14 |
| hepatica | 14 |
| https | 14 |
| los | 14 |
| national | 14 |
| ned | 14 |
| pH | 14 |
| preprint | 14 |
| δ | 14 |
| MEDLINE | 14 |
| Sent | 14 |
| bio | 14 |
| Sci | 14 |
| Principle | 14 |
| MG | 14 |
| SNPs | 14 |
| Major | 14 |
| Malaysia | 14 |
| Measures | 14 |
| Mechanisms | 14 |
| N. | 14 |
| Nielsen | 14 |
| PREM | 14 |
| Paris | 14 |
| Party | 14 |
| Nuclear | 14 |
| Psychology | 14 |
| Res | 14 |
| SLE | 14 |
| SB | 14 |
| Rome | 14 |
| SEM | 14 |
| Recovery | 14 |
| RP | 14 |
| Quarantelli | 14 |
| Games | 13 |
| Incident | 13 |
| George | 13 |
| Georgia | 13 |
| HAI | 13 |
| HML | 13 |
| HRQoL | 13 |
| Hand | 13 |
| Hu | 13 |
| IB | 13 |
| IHD | 13 |
| IVIG | 13 |
| Liquidity | 13 |
| Intervention | 13 |
| Island | 13 |
| James | 13 |
| Kaiser | 13 |
| Katrina | 13 |
| LEH | 13 |
| LM | 13 |
| Lawrence | 13 |
| Likert | 13 |
| Eyal | 13 |
| Literacy | 13 |
| Fund | 13 |
| ARG | 13 |
| Ethical | 13 |
| Environ | 13 |
| MacIntyre | 13 |
| ABO | 13 |
| Adolescent | 13 |
| Al | 13 |
| Alexander | 13 |
| Anxiety | 13 |
| Applied | 13 |
| Arizona | 13 |
| BCS | 13 |
| Biomedical | 13 |
| Braun | 13 |
| CL | 13 |
| Cell | 13 |
| Class | 13 |
| Consumer | 13 |
| DOXO | 13 |
| Daniel | 13 |
| Davis | 13 |
| Disasters | 13 |
| Dr | 13 |
| EID | 13 |
| Egypt | 13 |
| Enterococcus | 13 |
| MC | 13 |
| QResearch | 13 |
| Machine | 13 |
| STI | 13 |
| Score | 13 |
| Silva | 13 |
| Soc | 13 |
| Soviet | 13 |
| Stage | 13 |
| Std | 13 |
| Sydney | 13 |
| TOR | 13 |
| Test | 13 |
| Third | 13 |
| Thoracic | 13 |
| Uganda | 13 |
| VHF | 13 |
| Vaccination | 13 |
| WHRI | 13 |
| Zio | 13 |
| con | 13 |
| du | 13 |
| enterocolitica | 13 |
| iid | 13 |
| metformin | 13 |
| sulfamethoxazole | 13 |
| Mr. | 13 |
| Salus | 13 |
| Thai | 13 |
| SI | 13 |
| Pharmacokinetics | 13 |
| Ni | 13 |
| Röösli | 13 |
| OCD | 13 |
| OTF | 13 |
| Obama | 13 |
| Objectives | 13 |
| Options | 13 |
| PFOA | 13 |
| PTH | 13 |
| Pasteurella | 13 |
| Perspective | 13 |
| PFOS | 13 |
| Phillips | 13 |
| Randomized | 13 |
| Royal | 13 |
| Product | 13 |
| Robinson | 13 |
| Reger | 13 |
| Ratio | 13 |
| Roy | 13 |
| Qatar | 13 |
| ºC | 13 |
| QOL | 13 |
| Hypertension | 12 |
| Genome | 12 |
| German | 12 |
| Ghana | 12 |
| Grant | 12 |
| Gray | 12 |
| H7 | 12 |
| HAV | 12 |
| HEPA | 12 |
| Gene | 12 |
| HHV-6 | 12 |
| Holstein | 12 |
| MAP | 12 |
| IPC | 12 |
| Illness | 12 |
| Islands | 12 |
| Israel | 12 |
| Italian | 12 |
| Jonathan | 12 |
| Krugman | 12 |
| LOS | 12 |
| Lassa | 12 |
| Lim | 12 |
| Four | 12 |
| GA | 12 |
| A1 | 12 |
| Fever | 12 |
| Burkholderia | 12 |
| Mahn | 12 |
| ACEI | 12 |
| Acute | 12 |
| Adaptive | 12 |
| Agents | 12 |
| Australians | 12 |
| BN1 | 12 |
| BSC | 12 |
| Berlin | 12 |
| Boin | 12 |
| Borne | 12 |
| CFI | 12 |
| Federation | 12 |
| CWA | 12 |
| Canadian | 12 |
| Carolina | 12 |
| Company | 12 |
| Core | 12 |
| Country | 12 |
| Cr | 12 |
| Diet | 12 |
| Emergence | 12 |
| Evolution | 12 |
| Fear | 12 |
| MRA | 12 |
| Intensive | 12 |
| Mann | 12 |
| efavirenz | 12 |
| TLI | 12 |
| TPP | 12 |
| Testing | 12 |
| Vancouver | 12 |
| 12 | |
| Wilson | 12 |
| Xu | 12 |
| Yersinia | 12 |
| Zhou | 12 |
| casecontrol | 12 |
| covid | 12 |
| hyperoxemia | 12 |
| Surgeons | 12 |
| identifi | 12 |
| las | 12 |
| mmHg | 12 |
| nitrofurans | 12 |
| novo | 12 |
| posaconazole | 12 |
| rheumatoid | 12 |
| st | 12 |
| t. | 12 |
| ν | 12 |
| Mean | 12 |
| Surgery | 12 |
| methotrexate | 12 |
| Screening | 12 |
| Orleans | 12 |
| Meier | 12 |
| Schwartz | 12 |
| Murphy | 12 |
| NER | 12 |
| NY | 12 |
| NoGo | 12 |
| Nr | 12 |
| Nutrition | 12 |
| OST | 12 |
| Objective | 12 |
| Ontario | 12 |
| Neonatal | 12 |
| Overview | 12 |
| Personal | 12 |
| RA | 12 |
| SUD | 12 |
| P | 12 |
| Psychological | 12 |
| Post | 12 |
| Paul | 12 |
| Pandemrix | 12 |
| PaO | 12 |
| PS | 12 |
| GR | 11 |
| FEV1 | 11 |
| GHSA | 11 |
| GAO | 11 |
| Field | 11 |
| Gender | 11 |
| FSIQ | 11 |
| Enderwick | 11 |
| Executive | 11 |
| Excellence | 11 |
| Examination | 11 |
| Echinococcus | 11 |
| ESCMID | 11 |
| EMD | 11 |
| Groups | 11 |
| EEC | 11 |
| Generation | 11 |
| Knight | 11 |
| HNBC | 11 |
| HSV | 11 |
| DHS | 11 |
| Lewis | 11 |
| Le | 11 |
| Latinx | 11 |
| Laboratories | 11 |
| LVEF | 11 |
| Jackson | 11 |
| JACC | 11 |
| Individual | 11 |
| Independent | 11 |
| Imperial | 11 |
| IgG | 11 |
| ID | 11 |
| HbA1c | 11 |
| Hayes | 11 |
| DS | 11 |
| B3 | 11 |
| DF | 11 |
| Blood | 11 |
| Big | 11 |
| Becker | 11 |
| Bartonella | 11 |
| BK | 11 |
| BI | 11 |
| Azithromycin | 11 |
| Asset | 11 |
| Aro | 11 |
| Animals | 11 |
| Anderson | 11 |
| Allocation | 11 |
| Allergy | 11 |
| Aedes | 11 |
| ANN | 11 |
| ): | 11 |
| Bjorvatn | 11 |
| Blue | 11 |
| Covid | 11 |
| Brun | 11 |
| Contact | 11 |
| Comparative | 11 |
| Communications | 11 |
| M8 | 11 |
| Chief | 11 |
| Candida | 11 |
| Calf | 11 |
| CVR | 11 |
| CPZ | 11 |
| CNS | 11 |
| CN | 11 |
| CMS | 11 |
| CHR | 11 |
| CHIs | 11 |
| CENT | 11 |
| Lu | 11 |
| CoVaR | 11 |
| MB | 11 |
| doi | 11 |
| cognitive | 11 |
| apixaban | 11 |
| Zhu | 11 |
| Yu | 11 |
| Yan | 11 |
| Willebrand | 11 |
| Whitehall | 11 |
| Waste | 11 |
| WEF | 11 |
| WBC | 11 |
| Urban | 11 |
| Turner | 11 |
| Turkish | 11 |
| Transfusion | 11 |
| TST | 11 |
| dl | 11 |
| influenza | 11 |
| Surgical | 11 |
| key | 11 |
| ME | 11 |
| ∆v(x | 11 |
| λ | 11 |
| west | 11 |
| vi | 11 |
| sobre | 11 |
| sera | 11 |
| parvum | 11 |
| nomogram | 11 |
| nitrofurantoin | 11 |
| mm | 11 |
| methyldopa | 11 |
| lymphopenia | 11 |
| lumefantrine | 11 |
| les | 11 |
| TCC | 11 |
| granulosus | 11 |
| Substance | 11 |
| Power | 11 |
| Politics | 11 |
| Point | 11 |
| Performance | 11 |
| PCP | 11 |
| PCI | 11 |
| OA | 11 |
| Note | 11 |
| Nguyen | 11 |
| NIV | 11 |
| NCD | 11 |
| Michigan | 11 |
| Medicaid | 11 |
| Manufacturing | 11 |
| MR | 11 |
| Stuxnet | 11 |
| Potential | 11 |
| Obesity | 11 |
| STEMI | 11 |
| SCADA | 11 |
| Stock | 11 |
| Processes | 11 |
| Statement | 11 |
| Settings | 11 |
| Sanofi | 11 |
| San | 11 |
| SSM | 11 |
| Rolland | 11 |
| Richard | 11 |
| Regulatory | 11 |
| Regression | 11 |
| RTI | 11 |
| QT | 11 |
| Python | 11 |
| Prof. | 11 |
| Hepatocellular | 10 |
| Ground | 10 |
| Harrell | 10 |
| Harvey | 10 |
| Embase | 10 |
| Howard | 10 |
| Genetics | 10 |
| Hypotheses | 10 |
| Graduate | 10 |
| Emergencies | 10 |
| GVC | 10 |
| GSK | 10 |
| GC | 10 |
| Flaspöler | 10 |
| 10 | |
| Excel | 10 |
| EudraVigilance | 10 |
| IVF | 10 |
| Hypothesis | 10 |
| Los | 10 |
| Institutional | 10 |
| Interest | 10 |
| EOS | 10 |
| M3 | 10 |
| Lopinavir | 10 |
| Limpopo | 10 |
| License | 10 |
| Les | 10 |
| Leppin | 10 |
| Lemma | 10 |
| Lai | 10 |
| LN | 10 |
| Keller | 10 |
| Kahneman | 10 |
| KPNC | 10 |
| Jersey | 10 |
| Iron | 10 |
| Interpersonal | 10 |
| Internet | 10 |
| EcoHealth | 10 |
| ANC | 10 |
| EMEA | 10 |
| Chan | 10 |
| Capital | 10 |
| Cao | 10 |
| CRC | 10 |
| Bureau | 10 |
| Brooks | 10 |
| Boston | 10 |
| Basic | 10 |
| Articles | 10 |
| Application | 10 |
| Ali | 10 |
| Adolescents | 10 |
| Academic | 10 |
| ASCVD | 10 |
| MIT | 10 |
| AFA | 10 |
| AF | 10 |
| ACT | 10 |
| Capnocytophaga | 10 |
| Columbia | 10 |
| EDs | 10 |
| Common | 10 |
| Dunn | 10 |
| Douglas | 10 |
| Discussion | 10 |
| Denver | 10 |
| Dental | 10 |
| Death | 10 |
| Danish | 10 |
| DRSP | 10 |
| DPCM | 10 |
| DGS | 10 |
| Cryptosporidium | 10 |
| Credit | 10 |
| Countries | 10 |
| Cooperation | 10 |
| Contagion | 10 |
| Conditions | 10 |
| Comparison | 10 |
| MACE | 10 |
| Investment | 10 |
| MSM | 10 |
| Wong | 10 |
| Toxicology | 10 |
| Threat | 10 |
| Text | 10 |
| Technical | 10 |
| Tan | 10 |
| Surface | 10 |
| Sulawesi | 10 |
| Sudan | 10 |
| Spring | 10 |
| Spatial | 10 |
| Sleep | 10 |
| Short | 10 |
| Series | 10 |
| Sec | 10 |
| Schulze | 10 |
| Sardinia | 10 |
| ST | 10 |
| VRE | 10 |
| XO | 10 |
| SDP | 10 |
| Youth | 10 |
| MTurk | 10 |
| √ | 10 |
| в | 10 |
| und | 10 |
| systems | 10 |
| spp | 10 |
| simplex | 10 |
| pp | 10 |
| p15 | 10 |
| mebendazole | 10 |
| iot | 10 |
| immunodefi | 10 |
| comportamiento | 10 |
| cient | 10 |
| canimorsus | 10 |
| Zimbabwe | 10 |
| Zheng | 10 |
| SMB | 10 |
| artesunate | 10 |
| SCCS | 10 |
| Operations | 10 |
| Olsen | 10 |
| Oehmen | 10 |
| Number | 10 |
| Nipah | 10 |
| NP | 10 |
| NO2 | 10 |
| NIHR | 10 |
| NAC | 10 |
| Moran | 10 |
| Minnesota | 10 |
| Meyer | 10 |
| Metformin | 10 |
| Meeting | 10 |
| Medicines | 10 |
| Media | 10 |
| SC | 10 |
| Marketing | 10 |
| Oncology | 10 |
| ≤ | 10 |
| Organizations | 10 |
| Predictors | 10 |
| Road | 10 |
| Owen | 10 |
| Rev | 10 |
| Release | 10 |
| RDM | 10 |
| Psychiatric | 10 |
| Protective | 10 |
| Prime | 10 |
| RAS | 10 |
| Piesman | 10 |
| Pan | 10 |
| PET | 10 |
| PTLD | 10 |
| Pet | 10 |
| Rotterdam | 10 |
| Panels | 10 |
| Pediatrics | 10 |
| Experimental | 9 |
| FP | 9 |
| Ethiopia | 9 |
| Dynamics | 9 |
| Electricity | 9 |
| El | 9 |
| Economy | 9 |
| Early | 9 |
| ESBL | 9 |
| EMR | 9 |
| Estimating | 9 |
| Definition | 9 |
| Du | 9 |
| District | 9 |
| Distribution | 9 |
| Distress | 9 |
| Directorate | 9 |
| Dengue | 9 |
| Democratic | 9 |
| Foreign | 9 |
| Datta | 9 |
| Daszak | 9 |
| DHF | 9 |
| Cui | 9 |
| Crimean | 9 |
| Farhoudian | 9 |
| Good | 9 |
| Fraser | 9 |
| Frequency | 9 |
| Coronaviruses | 9 |
| Jacobian | 9 |
| JHC | 9 |
| Interdisciplinary | 9 |
| Innes | 9 |
| Immunisation | 9 |
| IGF-1 | 9 |
| IFN | 9 |
| IA | 9 |
| Household | 9 |
| Higgins | 9 |
| Herd | 9 |
| Herald | 9 |
| Hct | 9 |
| HRT | 9 |
| HCAP | 9 |
| Greeks | 9 |
| GlaxoSmithKline | 9 |
| Gerstein | 9 |
| Garcia | 9 |
| Gao | 9 |
| GERD | 9 |
| Fukushima | 9 |
| IEA | 9 |
| Annals | 9 |
| Consultation | 9 |
| Anesthesiologists | 9 |
| BRAT | 9 |
| BMT | 9 |
| BIM | 9 |
| BDV | 9 |
| BART | 9 |
| Atlantic | 9 |
| AstraZeneca | 9 |
| Art | 9 |
| Antiviral | 9 |
| Anti | 9 |
| Angeles | 9 |
| Amerithrax | 9 |
| Connecticut | 9 |
| Advanced | 9 |
| Activities | 9 |
| Academies | 9 |
| ASEAN | 9 |
| APACHE | 9 |
| AML | 9 |
| AGT | 9 |
| ACR | 9 |
| A(H1N1 | 9 |
| -3 | 9 |
| KCDC | 9 |
| Bacillus | 9 |
| Bahia | 9 |
| Barre | 9 |
| Barrett | 9 |
| Complex | 9 |
| Colombia | 9 |
| Co | 9 |
| Clarke | 9 |
| Claire | 9 |
| Cities | 9 |
| Chile | 9 |
| Chest | 9 |
| Chatterjee | 9 |
| Charles | 9 |
| Caribbean | 9 |
| Campbell | 9 |
| CVC | 9 |
| CV | 9 |
| COVID19 | 9 |
| CONT | 9 |
| CMR | 9 |
| CHI | 9 |
| CES | 9 |
| Burns | 9 |
| Brandt | 9 |
| Bayes | 9 |
| Baum | 9 |
| Johns | 9 |
| SVI | 9 |
| Kaposi | 9 |
| Tegeltija | 9 |
| WG | 9 |
| Visual | 9 |
| Veissier | 9 |
| Validation | 9 |
| VMI | 9 |
| VI | 9 |
| Universal | 9 |
| Units | 9 |
| Tsunami | 9 |
| Townsend | 9 |
| Tongji | 9 |
| TSE | 9 |
| Sausmarez | 9 |
| Synthesis | 9 |
| Swine | 9 |
| Spanish | 9 |
| Solidarity | 9 |
| Small | 9 |
| Simon | 9 |
| Siemens | 9 |
| Sensitivity | 9 |
| Select | 9 |
| Securities | 9 |
| Seasons | 9 |
| Wallis | 9 |
| Web | 9 |
| Wilmott | 9 |
| antiphospholipid | 9 |
| LD | 9 |
| α | 9 |
| valacyclovir | 9 |
| un | 9 |
| tau | 9 |
| s2 | 9 |
| rivaroxaban | 9 |
| r(413 | 9 |
| pyrimethamine | 9 |
| prednisone | 9 |
| p<0.01 | 9 |
| mucositis | 9 |
| mid | 9 |
| mental | 9 |
| mL | 9 |
| m3 | 9 |
| lactam | 9 |
| itraconazole | 9 |
| einer | 9 |
| drotrecogin | 9 |
| colchicine | 9 |
| chloramphenicol | 9 |
| cacy | 9 |
| Schaefer | 9 |
| cation | 9 |
| Saharan | 9 |
| MCLG | 9 |
| O. | 9 |
| Neumann | 9 |
| Neisseria | 9 |
| Needs | 9 |
| Nanjing | 9 |
| Mycoplasma | 9 |
| Modelling | 9 |
| Microsoft | 9 |
| Microbial | 9 |
| Macomer | 9 |
| MD | 9 |
| Linear | 9 |
| Observational | 9 |
| Lifetime | 9 |
| Liberia | 9 |
| Liang | 9 |
| Liability | 9 |
| Legionnaires | 9 |
| LYG | 9 |
| LPVr | 9 |
| LEK | 9 |
| LDL | 9 |
| SSRI | 9 |
| LDH | 9 |
| OHSS | 9 |
| List | 9 |
| Operation | 9 |
| Precautionary | 9 |
| SJS | 9 |
| SAS | 9 |
| Optimization | 9 |
| S3 | 9 |
| Ritchie | 9 |
| Resort | 9 |
| Related | 9 |
| RL | 9 |
| Queensland | 9 |
| Publisher | 9 |
| Production | 9 |
| RSC | 9 |
| Pandey | 9 |
| Plyushteva | 9 |
| Plague | 9 |
| Physicians | 9 |
| Perkins | 9 |
| Perceptions | 9 |
| Pasteur | 9 |
| Partnership | 9 |
| PDA | 9 |
| PCDD | 9 |
| Oseltamivir | 9 |
| ECG | 8 |
| Duncan | 8 |
| Equity | 8 |
| Drs | 8 |
| EHR | 8 |
| Dog | 8 |
| EFA | 8 |
| Educational | 8 |
| Everts | 8 |
| EORTC | 8 |
| Ecological | 8 |
| Empirical | 8 |
| Equipment | 8 |
| Disorders | 8 |
| DoS | 8 |
| DDoS | 8 |
| Dis | 8 |
| Diagnostic | 8 |
| DiValli | 8 |
| Di | 8 |
| Denial | 8 |
| Demographic | 8 |
| Delphi | 8 |
| Deception | 8 |
| Davies | 8 |
| DRR | 8 |
| Cyberbiosecurity | 8 |
| Cryptococcus | 8 |
| Cov-2 | 8 |
| FBI | 8 |
| Corona | 8 |
| Existential | 8 |
| Hunan | 8 |
| Form | 8 |
| GHP | 8 |
| Controlled | 8 |
| Implications | 8 |
| ITU | 8 |
| IMF | 8 |
| IIR | 8 |
| IDA | 8 |
| IAPD | 8 |
| Host | 8 |
| Hopwood | 8 |
| Holmes | 8 |
| Holm | 8 |
| Hodgkin | 8 |
| Heymann | 8 |
| Hematopoietic | 8 |
| Head | 8 |
| Hauge | 8 |
| Hallman | 8 |
| HMI | 8 |
| HI | 8 |
| HH | 8 |
| HCR | 8 |
| H5 | 8 |
| H2 | 8 |
| Gross | 8 |
| Gradient | 8 |
| Grade | 8 |
| Goals | 8 |
| Gleason | 8 |
| Girard | 8 |
| Convergence | 8 |
| Agreement | 8 |
| Complete | 8 |
| BUU | 8 |
| BOS | 8 |
| BN2 | 8 |
| BMS | 8 |
| Awareness | 8 |
| Avramov | 8 |
| Atlas | 8 |
| Atlanta | 8 |
| Assistance | 8 |
| Applications | 8 |
| Anopheles | 8 |
| Angiotensin | 8 |
| Andersen | 8 |
| Analytics | 8 |
| Amsterdam | 8 |
| Americas | 8 |
| Alert | 8 |
| Albers | 8 |
| Agricultural | 8 |
| Aerosol | 8 |
| Adult | 8 |
| Administrative | 8 |
| Actions | 8 |
| Achilles | 8 |
| Accountability | 8 |
| AST | 8 |
| APC | 8 |
| ACE-2 | 8 |
| AANA | 8 |
| Interaction | 8 |
| BPSD | 8 |
| BW | 8 |
| Competition | 8 |
| Barré | 8 |
| Companion | 8 |
| Collaborative | 8 |
| Collaboration | 8 |
| Clinic | 8 |
| Christopher | 8 |
| Cho | 8 |
| Chloramphenicol | 8 |
| Chlamydia | 8 |
| Chap | 8 |
| Caucasians | 8 |
| Carcinoma | 8 |
| Cambridge | 8 |
| Cambodia | 8 |
| CRISPR | 8 |
| CR | 8 |
| COTS | 8 |
| CNN | 8 |
| CNIDRS | 8 |
| CHEK2 | 8 |
| Brief | 8 |
| Bowen | 8 |
| Bostrom | 8 |
| Book | 8 |
| Binax | 8 |
| Billio | 8 |
| Berge | 8 |
| Belgium | 8 |
| Behav | 8 |
| Bartlett | 8 |
| Injury | 8 |
| Hybrid | 8 |
| Janeiro | 8 |
| Species | 8 |
| USDA | 8 |
| UF | 8 |
| Tucker | 8 |
| Tokyo | 8 |
| Tier | 8 |
| Thompson | 8 |
| Therapeutics | 8 |
| TRALI | 8 |
| TMPRSS2 | 8 |
| TA | 8 |
| Synthetic | 8 |
| Subcommittee | 8 |
| Student | 8 |
| Spread | 8 |
| Space | 8 |
| SF-36 | 8 |
| Solutions | 8 |
| Smallpox | 8 |
| Skills | 8 |
| Simulation | 8 |
| Shen | 8 |
| Seoul | 8 |
| Secure | 8 |
| Sector | 8 |
| Sect | 8 |
| Secretary | 8 |
| Scott | 8 |
| Scheme | 8 |
| SIV | 8 |
| SGA | 8 |
| Ukraine | 8 |
| Vincent | 8 |
| Viral | 8 |
| Wagner | 8 |
| Kenya | 8 |
| zur | 8 |
| vivo | 8 |
| tenofovir | 8 |
| review | 8 |
| pneumocystis | 8 |
| mass | 8 |
| labetalol | 8 |
| i.e | 8 |
| haemodialysis | 8 |
| group | 8 |
| empyema | 8 |
| diffi | 8 |
| didanosine | 8 |
| data | 8 |
| cryoprecipitate | 8 |
| congress | 8 |
| committee | 8 |
| bronchoalveolar | 8 |
| bei | 8 |
| b.w | 8 |
| atovaquone | 8 |
| amantadine | 8 |
| Zwart | 8 |
| Zhong | 8 |
| Year | 8 |
| Workplace | 8 |
| Walsh | 8 |
| Walker | 8 |
| SFTS | 8 |
| Zoonosis | 8 |
| Rock | 8 |
| Methicillin | 8 |
| Medellín | 8 |
| McKinsey | 8 |
| McGready | 8 |
| Matrix | 8 |
| Map | 8 |
| Ma | 8 |
| MTAP | 8 |
| MSD | 8 |
| MAX | 8 |
| Loneliness | 8 |
| Local | 8 |
| Liévanos | 8 |
| Living | 8 |
| Liverpool | 8 |
| Lithuania | 8 |
| Limited | 8 |
| Lessons | 8 |
| Lensink | 8 |
| League | 8 |
| Latinne | 8 |
| Latent | 8 |
| Lane | 8 |
| ∼ | 8 |
| Lagadec | 8 |
| LNLCA | 8 |
| LCA | 8 |
| KwaZulu | 8 |
| Kruskal | 8 |
| Robertson | 8 |
| Mekong | 8 |
| Liberg | 8 |
| Mitchell | 8 |
| Participation | 8 |
| Ribbon | 8 |
| Morning | 8 |
| Revolution | 8 |
| Resources | 8 |
| Rawson | 8 |
| Rates | 8 |
| Radositis | 8 |
| Pulmonary | 8 |
| Preventive | 8 |
| Pettit | 8 |
| Personnel | 8 |
| Perinatal | 8 |
| Pennington | 8 |
| Paulo | 8 |
| Psychiatry | 8 |
| Parkinson | 8 |
| Natal | 8 |
| Motivation | 8 |
| Palmer | 8 |
| Multicenter | 8 |
| NHANES | 8 |
| NIOSH | 8 |
| NTP | 8 |
| Morris | 8 |
| Next | 8 |
| Norwegian | 8 |
| OARAC | 8 |
| Oklahoma | 8 |
| PVL | 8 |
| Greenberg | 7 |
| Habermas | 7 |
| Griffiths | 7 |
| Guangzhou | 7 |
| Guinea | 7 |
| Granger | 7 |
| Gupta | 7 |
| HAART | 7 |
| Gregory | 7 |
| Ho | 7 |
| Hantavirus | 7 |
| Harrison | 7 |
| Hib | 7 |
| Hidden | 7 |
| Hooker | 7 |
| Hotel | 7 |
| Humans | 7 |
| Gill | 7 |
| Housing | 7 |
| Godoy | 7 |
| Fed | 7 |
| Giddens | 7 |
| GL | 7 |
| Ethik | 7 |
| ICUs | 7 |
| Extra | 7 |
| Faber | 7 |
| Faculty | 7 |
| Farm | 7 |
| Feng | 7 |
| Ferguson | 7 |
| Festival | 7 |
| Final | 7 |
| Finnish | 7 |
| Fire | 7 |
| Foster | 7 |
| Foundational | 7 |
| Fox | 7 |
| Francisco | 7 |
| Fulminant | 7 |
| Humetrix | 7 |
| Lopez | 7 |
| IOM | 7 |
| Lubatkin | 7 |
| Lazio | 7 |
| Lesotho | 7 |
| Leung | 7 |
| Levy | 7 |
| Linton | 7 |
| Liver | 7 |
| Livestock | 7 |
| Longitudinal | 7 |
| Lucia | 7 |
| IPCC | 7 |
| Lundborg | 7 |
| MCP-1 | 7 |
| MHC | 7 |
| MTB | 7 |
| MUHO | 7 |
| 7 | |
| Manual | 7 |
| Epidemics | 7 |
| Lalles | 7 |
| Labs | 7 |
| Lab | 7 |
| Kruger | 7 |
| IWHAI | 7 |
| Identification | 7 |
| Il | 7 |
| Improvement | 7 |
| Income | 7 |
| Infl | 7 |
| IoCPT | 7 |
| Iraq | 7 |
| Jan | 7 |
| Jobs | 7 |
| Johnston | 7 |
| Jongert | 7 |
| Kendall | 7 |
| Kent | 7 |
| Kidney | 7 |
| Klinke | 7 |
| Koch | 7 |
| Eric | 7 |
| Australasian | 7 |
| Eisen | 7 |
| Bird | 7 |
| BMC | 7 |
| BPSA | 7 |
| Bai | 7 |
| Baláž | 7 |
| Basel | 7 |
| Berg | 7 |
| Biodefense | 7 |
| Biosurveillance | 7 |
| Blumberg | 7 |
| Cas9 | 7 |
| Breast | 7 |
| Buckner | 7 |
| CBT | 7 |
| CCHF | 7 |
| CFU | 7 |
| CHA | 7 |
| CPNS | 7 |
| CS | 7 |
| Avin | 7 |
| Automation | 7 |
| Marrow | 7 |
| Atovaquone | 7 |
| 3D | 7 |
| 5-HTTLPR | 7 |
| ATP | 7 |
| Abuse | 7 |
| Acari | 7 |
| Accidents | 7 |
| Acyclovir | 7 |
| Adaptation | 7 |
| Advisories | 7 |
| Agenda | 7 |
| Akadiri | 7 |
| Anaplasma | 7 |
| Annual | 7 |
| Appendices | 7 |
| Asgary | 7 |
| Associations | 7 |
| Athens | 7 |
| CYP3A4 | 7 |
| Cases | 7 |
| Edwards | 7 |
| Dirichlet | 7 |
| DI | 7 |
| DIN | 7 |
| DOAC | 7 |
| DRB1 | 7 |
| Dan | 7 |
| Dapsone | 7 |
| Dark | 7 |
| Determinants | 7 |
| Document | 7 |
| Catastrophic | 7 |
| Dowd | 7 |
| Duffy | 7 |
| Dunning | 7 |
| Duty | 7 |
| EARSS | 7 |
| EEF | 7 |
| Earth | 7 |
| Editor | 7 |
| DG | 7 |
| DENV | 7 |
| Correlation | 7 |
| Coronary | 7 |
| Cd++ | 7 |
| Certificate | 7 |
| Certificates | 7 |
| Chagas | 7 |
| Challenge | 7 |
| Chengdu | 7 |
| Christian | 7 |
| Chu | 7 |
| Classen | 7 |
| Cloud | 7 |
| Codori | 7 |
| Colchicine | 7 |
| Commercial | 7 |
| Commodari | 7 |
| Communities | 7 |
| Concentration | 7 |
| Conclusions | 7 |
| Manuel | 7 |
| Haber | 7 |
| Master | 7 |
| Virginia | 7 |
| Turvey | 7 |
| Tversky | 7 |
| UNESCO | 7 |
| USAID | 7 |
| UT | 7 |
| Vaccines | 7 |
| Valentine | 7 |
| Vascular | 7 |
| WTO | 7 |
| Transport | 7 |
| Wage | 7 |
| Weekdays | 7 |
| Weekly | 7 |
| Wildlife | 7 |
| William | 7 |
| Williamson | 7 |
| Workshop | 7 |
| Yumagulova | 7 |
| Trip | 7 |
| Transplantation | 7 |
| Singer | 7 |
| Subheading | 7 |
| Staff | 7 |
| Standardization | 7 |
| Stata | 7 |
| Steiner | 7 |
| Stern | 7 |
| Stigma | 7 |
| Street | 7 |
| Stroop | 7 |
| SystmOne | 7 |
| Top | 7 |
| T1 | 7 |
| TARDIS | 7 |
| TTSH | 7 |
| TURBT | 7 |
| Technological | 7 |
| Temperature | 7 |
| Tercyak | 7 |
| Tools | 7 |
| Z | 7 |
| abomasal | 7 |
| b. | 7 |
| s1 | 7 |
| nitroimidazoles | 7 |
| paracetamol | 7 |
| parainfluenza | 7 |
| pro | 7 |
| protection | 7 |
| r(t | 7 |
| raltegravir | 7 |
| red | 7 |
| stavudine | 7 |
| biotics | 7 |
| teratologic | 7 |
| time | 7 |
| tofacitinib | 7 |
| tularensis | 7 |
| vedolizumab | 7 |
| ∞ | 7 |
| ≥75 | 7 |
| Matthew | 7 |
| ne | 7 |
| multocida | 7 |
| monocyte | 7 |
| mo | 7 |
| brinogen | 7 |
| cGVHD | 7 |
| cal | 7 |
| chloroquine | 7 |
| confi | 7 |
| di | 7 |